Fig. 1.
Fig. 1. Survival in Hodgkin's disease patients with refractory disease or in first relapse treated with either high-dose therapy and autografting (n = 60, solid line) or conventional salvage therapy (n = 103, dashed line). (A) Overall survival. Log-rank P = .25. (B) Event-free survival. Log-rank P < .01.

Survival in Hodgkin's disease patients with refractory disease or in first relapse treated with either high-dose therapy and autografting (n = 60, solid line) or conventional salvage therapy (n = 103, dashed line). (A) Overall survival. Log-rank P = .25. (B) Event-free survival. Log-rank P < .01.

or Create an Account

Close Modal
Close Modal